ACTIMMUNE

PHARMACEUTICAL PREPARATIONS, NAMELY, BIOLOGICALS RESPONSE MODIFIERS AND ANTIFIBROTIC AGENTS, PRIMARILY FOR USE AS (1) ANTI-INFECTIVE AGENTS FOR THE PREVENTION AND OR TREATMENT OF BACTERIAL, VIRAL OR FUNGAL INFECTIONS; (2) A TREATMENT FOR ABNORMAL PROLIFERATION OF FIBROBLASTIC CELLS SUCH AS KHELOIDS, BURNS OR SCLERODERMA; [ (3) AN ANTIPROLIFERATIVE AGENT FOR THE TREATMENT OF CANCER; (4) A TREATMENT FOR ALLERGIC DISEASES SUCH AS ATOPIC DERMITITIS, ASTHMA, AND ALLERGIC RHINITIS; AND (5) A TREATMENT FOR INFLAMATORY DISEASES SUCH AS CHRON'S DISEASE ]